Titan Pharmaceuticals
TTNP
#10306
Rank
C$4.73 M
Marketcap
$5.18
Share price
3.76%
Change (1 day)
-47.95%
Change (1 year)

Operating Margin for Titan Pharmaceuticals (TTNP)

Operating Margin as of March 2025 (TTM): -556,900.00%

According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -556,900.00%. At the end of 2023 the company had an Operating Margin of -556,900.00%.

Operating Margin history for Titan Pharmaceuticals from 2001 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-556,900.00%3173.96%
2022-17,010.00%382.62%
2021-3,524.50%156.47%
2020-1,374.21%-42.21%
2019-2,377.78%1457.69%
2018-152.65%-97.71%
2017-6,654.42%-19622.65%
201634.09%-105.05%
2015-674.99%924.13%
2014-65.91%-171.13%
201392.65%-143.44%
2012-213.29%-42.93%
2011-373.72%451.94%
2010-67.71%-99.08%
2009-7,360.76%
2007-76,804.17%49.43%
2006-51,396.88%98.44%
2005-25,900.00%-68.66%
2004-82,648.39%169.66%
2003-30,649.44%2669.68%
2002-1,106.60%109.5%
2001-528.22%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-20.45%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-856.84%-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,248.76%-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
26.37%-100.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
8.96%-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.